Aurora Biosciences (ABSC) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Aurora Biosciences (ABSC)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Boyce Burge who wrote (6)	9/24/1997 12:52:00 PM
From: dbuki	of 359

Thank you for your fascinating write-up of ABSC. I have one question. The terms of the agreements with BMY, LLY and WLA to develop and install the ultra-high throughput screening system ("UHTS") limit the number of such collaborators and users to 6 for "a limited period". Obviously, BMY, LLY, WLA and the yet unknown other 3 seek to gain competitive advantage through their co-exclusivity. To what extent is the co-exclusivity a limitation on ABSC's future opportunities? Would be useful to know what "a limited period" is in the agreements. You have referenced AFFX and INCY. AFFX is not limited in the number of chips they can sell, and INCY enters into non-exclusive licensing agreements with its clients.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next